The Foundation University Institute for Research in Primary Health Care Jordi Gol i Gurina (IDIAPJGoals) search volunteers with persistent covid infected in the last year and continue with breathing difficulties, to test the effectiveness of a drug which is currently used against asma.
Its about E-SPERANZA projectpromoted by the South Metropolitan Research Support Unit together with the Medicine Studies Unit of the IDIAP Jordi Gol, what do you need recruit more participants who continue to have respiratory problems more than a month after being infected with covid.
As only requirement to participate in the study, They must have been infected within the past year. People interested in participating in this study can contact the South Metropolitan Research Support Unit Until 15 June on the phone 938 575 545.
Affectation
He study it started in September 2021 to investigate the causes of persistent covid that affects one 10% of those infected, and find the medicine that can alleviate its effects.
Persistent covid symptoms may be present for more than six months and actually there is no treatment.
The dyspnoea, that is, the breathlessness, es one of the most frequent and disabling manifestations of covid persistent, have recalled those responsible for this essay, which consists of two parts.
The first is the randomized double-blind clinical trial, a method in which neither the doctor nor the patient knows whether the drug or placebo is being taken.
In this way, the effectiveness of the drug Montelukast in the mild symptoms of patients with persistent covid.
recruitment phase
The study is now in people recruitment phase with disease with more than four weeks of evolution and mild to moderate respiratory distress.
The drug being tested in this trial, Montelukast, already marketed for asthma and the researchers want to see if the drug is beneficial in reducing inflammation caused by SARS-CoV-2 infection.
The objective is to show that, versus placebo, This treatment is effective in improvement of quality of life Associated with respiratory symptoms in patients with persistent covid.
The second part of the study has as purpose learn more about the clinical features and biological of people with persistent covid.
Related news
To do this, they will analyze blood and stool samples of a subgroup of people participating in the clinical trial and thus determine the effect of the disease on the immune system, the intestinal flora and how it relates to the severity of persistent covid.
This part is done in collaboration with the Pneumology, Microbiology and Immunology Services of the Hospital de Bellvitge and the Pneumology Service of the Viladecans Hospital.
2023-04-26 12:29:21
#volunteers #persistent #covid #verify #effectiveness #drug
